Tag: Duchenne muscular dystrophy
Pfizer DMD drug domagrozumab fails in two clinical trials
Pfizer DMD drug update : US pharma giant Pfizer will scrap a couple of ongoing clinical trials evaluating its humanized monoclonal antibody domagrozumab (PF-06252616) for ... Read More
Potential Duchenne Muscular Dystrophy therapy from Exonics gets $5m boost
US based Exonics Therapeutics has secured $5 million seed funding from CureDuchenne Ventures, a subsidiary of nonprofit DMD advocacy group, CureDuchenne to advance its therapy ... Read More